| Palbociclib |
ENSG00000100181.17 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000104691.10 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000117242.7 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000117242.7 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000125804.9 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000160336.10 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000172965.10 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000173867.8 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000174680.5 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000175147.7 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000175773.8 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000175873.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000177337.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000177738.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Palbociclib |
ENSG00000177757.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000177788.5 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000177993.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000177993.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000178248.10 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000178440.5 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000178947.8 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000178977.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Palbociclib |
ENSG00000178977.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000179743.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000179859.7 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000180279.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000180279.5 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000180458.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000182057.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000182165.13 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000182310.8 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000182310.8 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000182404.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000184274.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000185044.10 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000185203.7 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000186369.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000187229.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000187621.10 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000187979.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000188206.5 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Palbociclib |
ENSG00000188424.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000196421.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000196559.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000196756.7 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000196951.6 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000197291.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000197558.7 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000197670.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000198106.7 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000203279.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000203288.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000203288.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000203327.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000203327.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000203497.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000203499.6 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000203588.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000203999.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000204011.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000204055.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000204241.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000204758.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000204758.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000204791.4 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000204815.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000204929.7 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000204934.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000205181.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000205266.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Palbociclib |
ENSG00000205628.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000205632.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000205837.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000205885.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000205913.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000206140.5 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000206337.6 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000206417.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000211683.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000213793.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000213863.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000213963.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000213971.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000213994.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000214184.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000214353.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000214353.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000214546.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000214650.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000214650.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000214719.7 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000214725.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000214770.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000214772.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000215190.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000215417.6 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000215424.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000215447.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000215458.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000215498.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000215498.4 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000217258.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Palbociclib |
ENSG00000222041.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000222041.6 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000222041.6 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000222044.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000223374.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000223379.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000223401.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Palbociclib |
ENSG00000223461.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000223473.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000223477.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000223528.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000223528.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000223573.2 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000223576.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000223576.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000223598.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000223598.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Palbociclib |
ENSG00000223768.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000223791.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000223806.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000223855.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000223891.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Palbociclib |
ENSG00000223891.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000223907.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000224043.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000224046.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000224079.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000224138.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000224174.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000224189.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000224251.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000224356.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000224429.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000224429.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000224468.3 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000224509.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000224533.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000224596.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000224597.5 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000224606.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000224621.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000224623.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000224713.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000224714.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000224789.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000224812.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000224817.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000224844.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000224883.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000224885.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000224885.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000224897.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000224934.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000224939.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Palbociclib |
ENSG00000224939.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000224959.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000224961.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000225030.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000225030.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Palbociclib |
ENSG00000225039.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000225146.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000225166.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000225172.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000225173.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000225194.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000225205.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000225216.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000225235.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000225265.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000225331.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000225335.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000225335.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000225353.2 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000225407.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000225489.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000225511.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000225518.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000225532.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000225578.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000225595.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000225675.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000225761.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000225762.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000225794.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000225794.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000225860.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000225880.4 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000225880.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000225889.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000225891.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000225905.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000225930.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000226047.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000226113.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000226194.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000226235.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Palbociclib |
ENSG00000226263.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000226281.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000226330.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000226332.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000226334.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000226349.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000226352.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000226375.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000226380.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000226390.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000226441.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Palbociclib |
ENSG00000226445.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000226453.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000226520.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000226578.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000226578.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000226648.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000226659.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000226684.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000226747.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000226756.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000226786.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000226833.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000226851.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000226872.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000226877.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000226891.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000226904.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000226950.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000226957.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000227006.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000227028.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Palbociclib |
ENSG00000227028.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000227050.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000227060.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Palbociclib |
ENSG00000227070.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000227071.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000227082.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000227116.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000227128.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000227188.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000227215.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000227220.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000227245.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000227252.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Palbociclib |
ENSG00000227256.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000227285.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000227354.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000227356.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000227373.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000227373.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000227392.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000227438.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000227480.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000227484.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000227486.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000227487.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000227496.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000227533.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000227543.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000227543.3 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000227591.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000227619.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000227627.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000227630.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000227640.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000227674.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000227704.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000227706.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000227711.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000227733.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000227740.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000227848.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000227857.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000227888.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000227906.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000227908.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000228022.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000228043.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000228043.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000228065.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000228106.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000228126.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000228141.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000228141.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000228172.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000228176.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000228222.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000228251.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000228251.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000228261.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000228274.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000228274.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000228293.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000228352.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000228386.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Palbociclib |
ENSG00000228389.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000228414.2 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000228420.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000228487.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000228495.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000228506.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000228509.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000228509.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000228526.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000228573.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000228624.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000228630.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Palbociclib |
ENSG00000228649.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000228682.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000228701.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000228741.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000228775.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000228779.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000228784.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Palbociclib |
ENSG00000228798.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000228889.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000228889.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000228906.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000228962.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000229036.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000229043.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000229081.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000229108.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000229118.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000229127.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000229140.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000229162.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000229191.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000229196.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000229203.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000229214.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000229214.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000229227.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000229276.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000229278.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000229325.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000229373.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000229431.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000229454.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000229528.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000229582.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000229591.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000229656.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000229723.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000229727.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000229776.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000229832.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000229839.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000229841.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000229867.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000229869.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000229869.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000229891.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000229931.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000229931.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Palbociclib |
ENSG00000229941.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000229950.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000230020.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000230090.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000230176.2 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000230212.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Palbociclib |
ENSG00000230410.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000230435.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000230487.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000230499.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000230499.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000230526.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000230530.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000230563.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000230565.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000230606.6 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000230699.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000230724.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000230729.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000230735.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000230753.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000230753.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000230798.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000230812.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000230880.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000230914.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000230928.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000230939.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000231057.3 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000231104.4 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000231104.4 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000231121.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000231125.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000231201.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000231212.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000231290.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000231298.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000231298.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000231304.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000231312.2 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000231327.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000231346.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000231429.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000231439.3 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000231483.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000231485.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Palbociclib |
ENSG00000231485.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000231507.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000231530.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000231566.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000231595.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000231607.4 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000231616.4 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000231636.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000231704.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000231711.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000231728.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000231770.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000231806.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000231811.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000231830.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000231856.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000231871.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000231877.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000231881.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000231881.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000231882.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000231908.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000231920.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000231948.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Palbociclib |
ENSG00000231966.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000231999.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000231999.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000232224.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000232284.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000232290.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000232324.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000232354.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000232363.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000232363.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000232412.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000232462.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000232470.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000232485.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000232530.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000232533.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000232536.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Palbociclib |
ENSG00000232545.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000232593.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000232623.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000232640.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000232725.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000232729.3 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000232739.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000232762.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000232762.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000232784.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000232803.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000232814.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000232827.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000232876.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000232912.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000232934.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Palbociclib |
ENSG00000232973.7 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000232977.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000232987.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000233006.2 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000233008.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000233029.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000233030.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000233056.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000233077.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000233117.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000233184.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000233203.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000233237.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000233251.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000233251.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000233255.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000233293.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000233387.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000233411.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000233429.5 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000233452.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000233483.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000233501.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000233509.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Palbociclib |
ENSG00000233509.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000233590.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000233651.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000233651.2 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000233665.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000233672.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000233757.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000233817.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000233825.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000233871.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000233895.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000233906.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000233922.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000234006.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000234028.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000234028.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000234142.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000234155.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000234181.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Palbociclib |
ENSG00000234206.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000234230.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000234264.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000234292.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000234361.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000234478.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000234492.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000234509.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000234509.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000234546.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000234610.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000234617.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000234650.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000234693.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000234753.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000234753.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000234753.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000234772.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000234779.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000234817.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000234860.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000234883.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000234899.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000234902.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000234912.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000234915.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000234921.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000234928.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000234996.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000235078.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000235079.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000235100.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000235117.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000235123.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000235172.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000235180.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000235189.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Palbociclib |
ENSG00000235280.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000235280.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000235408.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000235437.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Palbociclib |
ENSG00000235475.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000235477.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000235477.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000235481.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000235565.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000235590.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000235612.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000235629.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000235629.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000235660.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000235669.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000235688.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000235703.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000235706.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000235740.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000235772.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000235802.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000235806.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000235820.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000235830.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000235831.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000235837.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000235837.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000235884.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000235897.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Palbociclib |
ENSG00000235897.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000235897.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000235910.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000235919.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000235934.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000235954.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000235958.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000236003.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000236024.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000236051.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000236066.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000236166.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000236194.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000236230.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000236234.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000236255.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000236269.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000236299.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000236305.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000236318.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000236366.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000236393.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000236394.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000236426.3 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000236558.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000236591.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000236611.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000236643.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000236651.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Palbociclib |
ENSG00000236673.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Palbociclib |
ENSG00000236682.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000236687.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000236708.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000236711.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000236778.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000236810.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000236824.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000236830.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000236859.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000236869.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000236869.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000236869.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000236869.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000236886.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000236901.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000236914.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000236986.2 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000236990.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000236991.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000237015.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000237017.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000237036.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000237073.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000237094.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000237126.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000237126.4 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000237133.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Palbociclib |
ENSG00000237152.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000237152.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000237159.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000237188.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000237222.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000237222.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000237234.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000237250.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Palbociclib |
ENSG00000237253.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000237328.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Palbociclib |
ENSG00000237331.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000237356.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000237361.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000237371.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000237387.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000237404.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000237404.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000237436.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000237461.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000237476.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000237481.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000237484.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000237484.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000237491.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000237505.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000237513.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000237513.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000237520.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Palbociclib |
ENSG00000237525.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000237548.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000237587.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000237588.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Palbociclib |
ENSG00000237594.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000237686.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000237705.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000237718.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000237718.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000237726.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000237813.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000237819.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Palbociclib |
ENSG00000237819.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000237836.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000237853.2 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000237903.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000237927.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000237927.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000237937.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000237938.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000237950.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000238005.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Palbociclib |
ENSG00000238009.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000238035.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000238058.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000238113.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000238160.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000238197.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000238197.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000238198.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000238210.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000238210.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000238261.5 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000238280.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000239265.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000239462.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000239480.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000239945.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000240015.2 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000240063.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000240175.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000240211.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000240288.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000240288.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000240288.3 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000240288.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000240291.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000240373.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000240453.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000240497.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000240498.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000240591.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000240618.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000240666.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000240687.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000240731.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000240996.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000241155.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000241180.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000241269.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Palbociclib |
ENSG00000241288.3 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000241316.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000241520.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000241544.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000241666.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000241684.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000241764.3 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000241770.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000241770.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000241818.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000241832.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000241990.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000242147.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000242282.2 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000242349.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Palbociclib |
ENSG00000242396.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000242474.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000242516.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000242540.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000242553.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000242553.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000242622.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000242759.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000242902.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000243107.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000243243.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000243350.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000243766.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000243797.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000243885.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Palbociclib |
ENSG00000243926.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000244055.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000244124.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000244198.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000244286.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000244345.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000244393.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000244479.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000244649.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000244676.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000244879.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000245059.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000245060.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Palbociclib |
ENSG00000245148.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Palbociclib |
ENSG00000245281.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000245479.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000245522.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000245614.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000245812.2 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000245857.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000245928.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000246145.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000246465.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000246528.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000246582.2 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000246627.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000246640.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000246640.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000246740.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Palbociclib |
ENSG00000246763.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000246859.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000246982.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000247213.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000247240.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000247271.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000247372.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000247381.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Palbociclib |
ENSG00000247416.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000247556.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000247595.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000247796.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000247844.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000247934.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000247970.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000248019.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000248019.2 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000248112.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000248143.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000248265.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000248275.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000248323.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000248367.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000248399.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000248429.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000248468.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000248476.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000248587.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000248596.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000248596.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000248629.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000248664.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000248677.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000248693.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000248758.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000248771.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000248774.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000248787.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000248810.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000248859.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000248896.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000248932.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000248996.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000248996.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000249035.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000249085.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000249207.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Palbociclib |
ENSG00000249241.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000249249.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000249258.2 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000249258.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000249306.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Palbociclib |
ENSG00000249307.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000249348.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000249352.3 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000249359.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000249409.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000249430.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000249483.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000249494.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000249621.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000249637.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000249650.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000249669.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000249685.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000249685.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000249736.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000249740.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000249753.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000249803.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000249846.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000249867.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000249875.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000249899.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000249996.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000250033.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Palbociclib |
ENSG00000250039.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000250056.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000250057.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000250061.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000250075.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000250234.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000250240.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000250366.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000250371.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000250410.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000250432.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000250451.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000250602.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000250608.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000250616.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000250659.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000250699.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000250714.3 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000250740.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000250748.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000250748.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000250748.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000250786.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Palbociclib |
ENSG00000250786.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000250842.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000250842.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Palbociclib |
ENSG00000251003.3 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000251009.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000251031.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000251085.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000251093.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000251131.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Palbociclib |
ENSG00000251131.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000251136.4 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000251141.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000251161.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000251171.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000251175.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000251194.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000251273.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000251273.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Palbociclib |
ENSG00000251301.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000251309.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000251330.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000251331.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000251442.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000251442.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000251602.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000251615.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000251615.3 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000251623.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000251637.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000253161.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000253187.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000253187.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000253217.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000253284.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Palbociclib |
ENSG00000253308.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000253392.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000253399.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000253405.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000253507.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000253522.2 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000253559.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000253618.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000253618.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000253636.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000253641.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000253649.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000253653.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000253696.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000253696.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000253704.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000253704.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000253726.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000253733.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000253844.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000253864.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000253864.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000253878.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000253961.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000253978.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000253986.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000254109.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000254129.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000254144.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000254162.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000254187.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000254205.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000254224.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000254267.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000254275.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Palbociclib |
ENSG00000254340.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000254363.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000254363.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000254369.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000254416.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000254432.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Palbociclib |
ENSG00000254432.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000254438.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000254473.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000254526.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000254528.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000254539.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000254539.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000254551.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000254557.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000254602.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000254604.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000254615.2 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000254638.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000254687.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000254703.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Palbociclib |
ENSG00000254710.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000254718.2 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000254739.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000254777.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000254802.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000254812.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000254812.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000254854.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000254855.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000254859.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000254869.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000254910.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000254929.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000254929.2 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000254981.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000255008.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000255020.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000255026.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000255031.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000255031.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Palbociclib |
ENSG00000255031.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000255121.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000255142.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000255142.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000255164.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000255176.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000255176.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000255186.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000255227.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000255237.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000255276.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000255322.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000255326.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000255334.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000255343.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000255409.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000255435.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000255458.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000255542.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000255559.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000255568.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000255571.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000255571.2 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000255621.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000255621.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Palbociclib |
ENSG00000255843.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000255866.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Palbociclib |
ENSG00000255867.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Palbociclib |
ENSG00000255867.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000255867.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000255871.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000255921.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000256006.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000256020.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000256092.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000256128.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000256226.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000256232.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000256237.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000256250.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000256268.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000256312.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000256314.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000256360.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000256433.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000256443.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000256448.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000256448.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000256448.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000256582.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Palbociclib |
ENSG00000256789.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000256811.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000256894.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000256984.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000257002.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000257004.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000257027.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000257058.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000257058.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000257058.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000257084.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000257097.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000257167.2 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000257176.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000257191.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000257252.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Palbociclib |
ENSG00000257261.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000257277.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000257285.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000257322.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000257337.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000257346.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000257443.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Palbociclib |
ENSG00000257449.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000257449.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000257497.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Palbociclib |
ENSG00000257497.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000257534.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000257563.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000257621.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000257621.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000257671.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000257696.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000257698.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000257702.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000257742.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000257829.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000257830.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000257883.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000257894.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000257913.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000257999.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000258077.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000258086.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000258088.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000258099.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Palbociclib |
ENSG00000258101.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000258102.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000258162.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000258199.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000258268.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000258302.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000258302.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000258346.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000258413.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000258413.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000258413.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000258422.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000258479.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000258502.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000258520.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000258620.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000258623.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000258646.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000258646.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000258682.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000258701.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000258711.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000258725.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000258731.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000258857.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000258858.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000258858.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000258920.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000258949.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000258949.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Palbociclib |
ENSG00000258952.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000258957.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000258976.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000259038.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000259054.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000259055.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000259062.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000259081.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000259084.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000259130.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000259153.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000259187.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000259215.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000259218.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000259219.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000259219.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000259238.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000259240.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000259241.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000259242.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000259296.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000259310.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000259319.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000259322.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000259327.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Palbociclib |
ENSG00000259376.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000259377.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000259416.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Palbociclib |
ENSG00000259417.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000259426.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000259426.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000259438.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000259442.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000259462.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000259474.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000259520.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000259583.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000259587.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000259588.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000259598.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000259606.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000259635.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000259654.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000259687.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000259694.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000259704.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000259711.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000259714.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000259727.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000259744.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000259768.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000259772.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000259783.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000259783.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000259818.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000259826.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000259834.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000259843.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000259843.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000259876.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000259883.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000259891.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000259894.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000259894.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000259901.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000259921.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000259926.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000259937.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000259974.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Palbociclib |
ENSG00000260006.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000260008.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000260008.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000260015.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000260030.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000260032.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000260038.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000260065.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000260083.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000260084.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Palbociclib |
ENSG00000260088.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000260101.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000260132.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000260141.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000260145.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000260160.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Palbociclib |
ENSG00000260177.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000260177.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000260179.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000260196.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000260198.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000260209.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000260213.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000260213.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000260252.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000260261.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000260288.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000260293.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000260296.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000260317.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000260336.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000260368.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000260368.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000260400.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000260411.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Palbociclib |
ENSG00000260423.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000260439.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Palbociclib |
ENSG00000260441.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000260455.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000260466.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000260468.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000260469.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000260470.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000260498.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000260545.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Palbociclib |
ENSG00000260552.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000260555.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000260579.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000260588.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000260589.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000260597.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000260614.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000260645.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000260648.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000260648.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000260655.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000260660.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000260660.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000260677.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000260735.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000260742.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000260742.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000260744.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Palbociclib |
ENSG00000260750.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000260792.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000260803.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000260805.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000260831.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000260838.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000260874.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000260877.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000260891.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000260905.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000260910.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000260912.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000260917.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000260918.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000260923.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000260924.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000260929.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000260931.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000260932.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000260992.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000260996.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000260996.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000261002.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000261002.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000261005.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000261024.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000261033.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000261083.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000261083.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000261087.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000261096.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000261098.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000261098.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000261126.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000261126.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000261135.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000261135.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000261140.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000261159.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000261167.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000261186.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000261189.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000261216.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000261220.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000261231.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000261253.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000261291.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000261295.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000261324.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000261337.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000261337.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000261355.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000261369.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000261402.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000261404.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000261407.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000261420.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000261423.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000261425.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000261431.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000261431.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000261435.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000261447.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000261451.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Palbociclib |
ENSG00000261455.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000261462.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000261468.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000261469.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000261469.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000261478.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000261490.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000261490.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000261496.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000261504.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000261529.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000261533.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000261533.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000261534.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000261570.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000261589.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000261596.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000261600.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000261630.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000261644.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000261645.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000261662.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000261662.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000261669.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000261736.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000261744.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000261766.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000261770.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000261775.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000261801.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000261804.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000261827.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000261840.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000261864.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000261879.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000261978.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000262001.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000262074.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000262074.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000262115.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000262188.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Palbociclib |
ENSG00000262202.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000262223.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000262339.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000262339.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000262372.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000262514.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000262585.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000262652.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000262663.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000262678.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000262721.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000262745.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000262768.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000262772.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000262772.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000262801.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000262815.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000262833.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000262848.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000262873.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000262903.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000262905.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000262920.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000263050.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000263063.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000263069.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000263069.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000263072.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000263080.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000263080.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000263098.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000263120.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000263176.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000263316.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000263327.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000263388.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Palbociclib |
ENSG00000263388.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000263412.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000263466.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Palbociclib |
ENSG00000263466.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000263627.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000263677.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000263717.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000263727.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000263731.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000263786.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000263874.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000263931.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000264043.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000264043.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000264043.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000264080.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000264125.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000264207.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000264235.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000264247.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000264304.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000264448.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000264469.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000264527.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000264569.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000264575.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000264630.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000264729.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000264769.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000264860.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000264895.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000264924.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000265130.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000265185.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000265205.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000265218.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Palbociclib |
ENSG00000265242.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000265369.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000265399.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000265413.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000265485.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000265519.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000265656.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000265692.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000265739.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000265778.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000266040.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000266040.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000266053.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000266088.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000266111.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Palbociclib |
ENSG00000266236.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000266236.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000266368.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000266371.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000266401.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Palbociclib |
ENSG00000266402.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000266446.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000266473.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000266654.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Palbociclib |
ENSG00000266677.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000266717.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000266783.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000266805.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000266877.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000266904.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000266908.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000266921.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000266936.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000266942.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000266947.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000266969.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000266970.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000266975.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000266976.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000266983.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000266987.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Palbociclib |
ENSG00000266993.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000266999.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000266999.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Palbociclib |
ENSG00000267003.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000267016.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000267018.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000267018.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000267024.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000267034.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000267040.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000267042.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000267044.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000267063.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Palbociclib |
ENSG00000267064.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000267095.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000267115.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Palbociclib |
ENSG00000267131.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Palbociclib |
ENSG00000267131.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000267141.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000267143.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000267161.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000267161.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Palbociclib |
ENSG00000267166.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000267197.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000267201.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000267219.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000267221.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000267221.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000267262.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000267263.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000267277.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000267278.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000267280.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000267302.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000267316.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000267345.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000267366.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000267372.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000267375.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000267380.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000267381.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000267388.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000267390.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000267395.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000267397.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000267397.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000267397.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000267414.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000267421.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000267424.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000267437.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000267449.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000267454.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000267457.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000267470.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000267475.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000267480.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000267493.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000267519.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000267519.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000267530.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000267583.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Palbociclib |
ENSG00000267588.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000267606.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000267644.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000267654.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000267655.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000267677.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000267690.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000267709.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000267730.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000267747.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000267758.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000267759.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Palbociclib |
ENSG00000267776.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000267783.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000267787.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000267798.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000267804.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000267904.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000267905.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000267919.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000267927.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000268001.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000268015.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000268047.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000268049.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000268087.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000268093.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000268204.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000268266.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000268333.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000268364.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000268518.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000268543.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000268568.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000268583.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000268601.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000268605.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000268605.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000268670.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000268683.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Palbociclib |
ENSG00000268756.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000268812.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000269082.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000269086.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000269107.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000269161.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000269365.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000269427.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000269427.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000269439.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000269444.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000269463.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000269473.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000269486.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000269486.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000269487.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000269609.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000269609.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000269609.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000269646.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000269680.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000269792.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000269836.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000269911.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000269919.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000269921.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000269934.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Palbociclib |
ENSG00000269954.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000269967.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Palbociclib |
ENSG00000269978.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000269980.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000269997.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000270009.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000270015.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000270022.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000270035.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000270040.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000270049.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000270050.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000270055.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000270066.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000270067.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000270071.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000270074.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000270074.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Palbociclib |
ENSG00000270091.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000270093.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000270095.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000270103.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Palbociclib |
ENSG00000270104.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000270109.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000270117.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000270130.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000270143.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000270165.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Palbociclib |
ENSG00000270170.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000270173.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000270184.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000270189.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000270190.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000270195.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000270210.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000270210.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000270246.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000270246.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000270344.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000270372.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000270599.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Palbociclib |
ENSG00000270604.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000270605.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000270605.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000270640.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000270697.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000270761.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000270828.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000270988.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000270996.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000271020.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000271032.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000271172.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000271228.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000271265.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000271324.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000271324.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000271327.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000271335.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000271398.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000271427.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000271551.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000271590.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000271590.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000271643.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000271643.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000271709.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000271727.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000271732.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Palbociclib |
ENSG00000271734.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000271738.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000271751.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000271757.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000271762.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000271780.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000271803.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000271830.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000271833.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000271845.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000271882.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000271911.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000271913.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000271914.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000271948.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000271967.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000271991.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000271993.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000271997.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000272002.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000272005.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000272024.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000272040.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000272049.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000272065.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000272077.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000272088.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000272091.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000272103.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000272108.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000272123.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Palbociclib |
ENSG00000272128.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000272142.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000272142.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000272143.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000272161.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000272167.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000272168.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000272168.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000272180.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000272183.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000272205.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000272219.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Palbociclib |
ENSG00000272226.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000272233.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000272236.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000272250.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000272263.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000272265.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000272273.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000272288.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000272301.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000272316.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Palbociclib |
ENSG00000272316.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000272334.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000272341.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Palbociclib |
ENSG00000272346.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000272361.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000272366.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000272366.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000272372.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000272373.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000272373.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000272384.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000272386.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000272416.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000272417.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000272425.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000272425.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000272430.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000272438.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000272449.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000272452.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000272468.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000272468.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000272479.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000272505.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000272508.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000272518.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000272519.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000272520.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000272523.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000272576.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000272576.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000272610.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000272622.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000272646.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000272650.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Palbociclib |
ENSG00000272659.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000272662.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000272668.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000272677.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000272695.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000272696.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000272732.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000272744.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000272758.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000272761.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000272764.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000272782.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000272798.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000272828.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000272829.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000272836.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000272848.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000272858.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000272858.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000272864.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000272888.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000272895.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000272908.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000272912.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000272917.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000272931.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000272940.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000272954.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000272954.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000272960.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000272970.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000272977.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Palbociclib |
ENSG00000273001.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000273004.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000273008.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000273019.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000273026.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000273035.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000273038.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000273065.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000273071.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000273076.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000273084.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000273091.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000273102.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Palbociclib |
ENSG00000273116.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000273117.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000273156.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000273156.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000273162.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000273165.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000273176.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000273179.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000273185.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000273216.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000273232.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000273233.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000273237.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000273243.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000273247.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000273253.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000273253.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Palbociclib |
ENSG00000273264.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000273271.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Palbociclib |
ENSG00000273271.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000273271.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000273281.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000273287.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000273289.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000273289.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000273289.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Palbociclib |
ENSG00000273290.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000273295.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000273295.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000273305.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000273305.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Palbociclib |
ENSG00000273306.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000273308.1 |
Predicted lncRNA |
Sarcoma |
|
| Palbociclib |
ENSG00000273313.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000273342.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000273342.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Palbociclib |
ENSG00000273353.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Palbociclib |
ENSG00000273372.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000273384.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Palbociclib |
ENSG00000273464.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Palbociclib |
ENSG00000273471.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Palbociclib |
ENSG00000273474.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Palbociclib |
ENSG00000273483.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Palbociclib |
ENSG00000273488.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Palbociclib |
ENSG00000273492.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
